A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer

A phase II trial of endoscopic submucosal dissection (ESD) for superficial pharyngeal cancer - A phase II trial of ESD for superficial pharyngeal cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003623

Enrollment

Registered

2010-05-17

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

superficial pharyngeal cancer

Interventions

Endoscopic submucosal dissection (ESD)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Superficial pharyngeal carcinoma confined to subepithelial lesion without lymphnode metastasis.

Exclusion criteria

Exclusion criteria: 1)Patients with hematologicalabnormality 2)Active synchronous or metachronous malignancy 3)Patients with severe organ failure 4)Others who were thought to be unsuitable by the investigator. 5)Patients who underwent radiation therapy.

Design outcomes

Primary

Measure	Time frame
Complete en block resection rate	—

Countries

Japan

Contacts

Public ContactNoboru Hanaoka

Osaka Medical Center for Cancer and Cardiovascular Diseases Gastrointestinal Oncology

hanaoka-no@mc.pref.osaka.jp06-672-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026